Literature DB >> 16757159

Calcium stone lithoptysis in primary ciliary dyskinesia.

Marcus P Kennedy1, Peadar G Noone, John Carson, Paul L Molina, Andrew Ghio, Maimoona A Zariwala, Susan L Minnix, Michael R Knowles.   

Abstract

BACKGROUND: An association between lithoptysis and primary ciliary dyskinesia (PCD) has not been previously reported. However, reports of lithoptysis from 2 older patients (>60 yr) prompted a study of this association.
METHODS: We performed a prospective study of all PCD patients presenting to our institution between August 2003 and March 2006, seeking the symptom of lithoptysis or calcium deposition on radiology. A retrospective analysis of all PCD patients presenting prior to August 2003 was also performed. Patients age > or = 40 previously reviewed were recontacted. If a history of lithoptysis or calcium deposition was present, we further reviewed radiographic, microbiologic, and biochemical data, including serum calcium and phosphate. Broncholiths were analyzed by light and electron microscopy- and electron-dispersive X-ray analysis.
RESULTS: In total, 142 patients (n=28 age > or = 40) were included, 41 in the prospective and 91 in the retrospective study. Lithoptysis was reported in 5 patients (all age > or = 40). Chest CT scans identified calcification (4/5), involving bronchiectatic airways in 3 patients and focal nodular calcification in 1 patient. Two other patients (age 46, 59) were identified with airway calcification without lithoptysis. Available broncholiths from 2 of these patients were composed of calcite, whereas a broncholith from 1 patient with focal nodular calcification contained calcium phosphate. Sputum was positive for Pseudomonas aeruginosa in all 7 patients, but negative for mycobacterial and fungal cultures.
CONCLUSION: There is an association between lithoptysis and PCD in patients age > or = 40. We hypothesize that calcite stone formation is a biomineralization response to chronic airway inflammation and retention of infected airway secretions in PCD in a subset of PCD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757159     DOI: 10.1016/j.rmed.2006.04.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  Primary ciliary dyskinesia, an orphan disease.

Authors:  Mieke Boon; Mark Jorissen; Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

2.  Spatial patterns of carbonate biomineralization in biofilms.

Authors:  Xiaobao Li; David L Chopp; William A Russin; Paul T Brannon; Matthew R Parsek; Aaron I Packman
Journal:  Appl Environ Microbiol       Date:  2015-08-14       Impact factor: 4.792

Review 3.  Management of broncholithiasis.

Authors:  Sheila Krishnan; Christopher M Kniese; Mark Mankins; Darel E Heitkamp; Francis D Sheski; Kenneth A Kesler
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

4.  In Situ Biomineralization and Particle Deposition Distinctively Mediate Biofilm Susceptibility to Chlorine.

Authors:  Xiaobao Li; David L Chopp; William A Russin; Paul T Brannon; Matthew R Parsek; Aaron I Packman
Journal:  Appl Environ Microbiol       Date:  2016-05-02       Impact factor: 4.792

Review 5.  Primary ciliary dyskinesia and upper airway diseases.

Authors:  Marcus P Kennedy; Lawrence E Ostrowski
Journal:  Curr Allergy Asthma Rep       Date:  2006-11       Impact factor: 4.919

6.  Cryo-electron tomography reveals ciliary defects underlying human RSPH1 primary ciliary dyskinesia.

Authors:  Jianfeng Lin; Weining Yin; Maria C Smith; Kangkang Song; Margaret W Leigh; Maimoona A Zariwala; Michael R Knowles; Lawrence E Ostrowski; Daniela Nicastro
Journal:  Nat Commun       Date:  2014-12-04       Impact factor: 14.919

Review 7.  Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

Authors:  Florian Gahleitner; James Thompson; Claire L Jackson; Jana F Hueppe; Laura Behan; Eleonora Dehlink; Myrofora Goutaki; Florian Halbeisen; Ana Paula L Queiroz; Guillaume Thouvenin; Claudia E Kuehni; Philipp Latzin; Jane S Lucas; Bruna Rubbo
Journal:  ERJ Open Res       Date:  2021-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.